دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
- :
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
How to make a shared decision with older persons for end-stage kidney disease treatment: the added value of geronto-nephrology Open Access
doi : 10.1093/ckj/sfae281
Volume 17, Issue 10, October 2024
Ethics in humanitarian settings—relevance and consequences for dialysis and kidney care Open Access
doi : 10.1093/ckj/sfae290
The role of kidney biopsy in the diagnosis of membranous nephropathy Open Access
doi : 10.1093/ckj/sfae292
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation
doi : 10.1093/ckj/sfae270
Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis Open Access
doi : 10.1093/ckj/sfae256
Post-transplant renal anemia: a call to action from a national study in routine clinical practice Open Access
doi : 10.1093/ckj/sfae269
Sex and gender differences in health-related quality of life in individuals treated with incremental and conventional hemodialysis Open Access
doi : 10.1093/ckj/sfae273
Associations between acute kidney injury and bone fractures: a retrospective cohort study Open Access
doi : 10.1093/ckj/sfae282
Machine learning models for mortality prediction in critically ill patients with acute pancreatitis–associated acute kidney injury Open Access
doi : 10.1093/ckj/sfae284
The effects of dialysate calcium prescription on mortality outcomes in incident patients on hemodialysis Open Access
doi : 10.1093/ckj/sfae288
The benefit of reduced serum phosphate levels depends on patient characteristics: a nationwide cohort study Open Access
doi : 10.1093/ckj/sfae263
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study Open Access
doi : 10.1093/ckj/sfae285
Cerebral white matter injury in haemodialysis patients: a cross-sectional tract-based spatial statistics and fixel-based analysis Open Access
doi : 10.1093/ckj/sfae286
Mid- and long-term renal outcomes after metabolic surgery in a multi-center, multi-ethnic Asian cohort with T2DM Open Access
doi : 10.1093/ckj/sfae260
Chronic kidney disease–associated pruritus and quality of life with difelikefalin treatment: a post hoc analysis of phase 3 data using the Skindex-10 questionnaire Open Access
doi : 10.1093/ckj/sfae274
Apolipoprotein B-48 and late graft failure in kidney transplant recipients Open Access
doi : 10.1093/ckj/sfae289
Modified creatinine index as a marker of skeletal muscle mass in peritoneal dialysis patients Open Access
doi : 10.1093/ckj/sfae297
The weighing process in patients on hemodialysis: an opportunity to improve volume management Open Access
doi : 10.1093/ckj/sfae275
Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis Open Access
doi : 10.1093/ckj/sfae302
Tolvaptan and the role of kidney aquaporin-2 abundance in managing volume overload in patients with CKD Open Access
doi : 10.1093/ckj/sfae303
N-terminal pro-B-type natriuretic peptide, eGFR, and progression of kidney disease in chronic kidney disease patients without heart failure Open Access
doi : 10.1093/ckj/sfae298
Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making Open Access
doi : 10.1093/ckj/sfae295
Chronic kidney disease–associated pruritus: a comparison of instruments and associations with patient-reported outcomes using an electronic patient-reported outcome survey in Europe Open Access
doi : 10.1093/ckj/sfae276
Correction to: Reduction in kidney function decline and risk of severe clinical events in agalsidase beta–treated Fabry disease patients: a matched analysis from the Fabry Registry Open Access
doi : 10.1093/ckj/sfae304
